About Us

Established in 2013, Maxpro Ventures is a biomedical technology investment firm identifying companies developing innovative drugs, devices, diagnostics, and services to fulfill people’s unmet medical needs and change their lives. We primarily focus on companies developing next-generation cell/gene therapies, biologic drugs, medical devices, diagnostics, and healthcare services.

At Maxpro Ventures, we create and discover value in the biomedical technology industry. We have been investing globally across the healthcare industry, from early-stage small companies to late-stage multinational corporations. We are committed investors and work closely with our portfolio companies to maximize their profits and success.

Maxpro Ventures’ team includes experienced professionals with in-depth knowledge of biotechnology, pharmaceuticals, business development, and finance. We provide our portfolio companies with operational expertise, management support, and a global network. We leverage our extensive relationships, industry operating experience, and a disciplined investment approach to add considerable value to our portfolio companies and to generate substantial investment returns for our investors.